Address	11 Hurley Street Cambridge Massachusetts 02142 United States
Employees	-
Website	http://www.editasmedicine.com
Updated	07/08/2019
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A.